Allurion Technologies Faces NYSE Compliance Hurdle

Allurion Technologies ( (ALUR) ) has provided an announcement.

Allurion Technologies, Inc., a healthcare company focused on obesity treatments, has been notified by the NYSE of non-compliance with listing standards due to its market capitalization falling below $50 million. The company plans to submit a remedial plan within 45 days to regain compliance within an 18-month period. The stock will continue to trade under the ticker “ALUR” with a “.BC” designation indicating its below-criteria status. The compliance issue is not expected to affect Allurion’s business operations or SEC reporting obligations.

For a thorough assessment of ALUR stock, go to TipRanks’ Stock Analysis page.